CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion

CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion

来源:WSJ发布于 2026-10-06

Under the agreement, CD&R will hold a majority interest of about 51% in Option Care Health, while McKesson will hold about 49%.

相关标的:MCK

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。